Lutathera (lutetium 177 dotatate)

pCPA File Number: 22028
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of unresectable or metastatic, well-differentiated, somatostatin receptor (SSR)–positive pancreatic neuroendocrine tumours (pNETs) in adults whose disease has progressed after treatment with a somatostatin analogue (SSA), unless there is a contraindication or intolerance
Sponsor/Manufacturer:
Advanced Accelerator Applications
CADTH Project Number:
PC0284
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable